Concepedia

Megan M. Herr

MM

25

Publications

949

Citations

16

H-Index

2010

Active since

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Medical College of Wisconsin

The University of Texas MD Anderson Cancer Center

Moffitt Cancer Center

Dana-Farber Cancer Institute

Megan M. Herr is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2010–2025

25

Publications

25

Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States

Caron A. Jacobson, Frederick L. Locke, Long Ma et al. · Transplantation and Cellular Therapy · 2022 · 166 citations · Full text

, , +21

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

Ephraim J. Fuchs, Shannon R. McCurdy, Scott R. Solomon et al. · Blood · 2021 · 109 citations · Full text

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Surbhi Sidana, Krina K. Patel, Lauren C. Peres et al. · Blood · 2024 · 92 citations · Full text

Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma

Maximilian Merz, Almuth Maria Anni Merz, Jie Wang et al. · Nature Communications · 2022 · 63 citations · Full text

, , +21

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer

Aram F. Hezel, Marcus Smith Noel, Jill N. Allen et al. · British Journal of Cancer · 2014 · 58 citations · Full text

Rows per page

1–5 of 25